Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization

Molecular Pharmacology

Volumn 67, Issue 3, 2005, Pages 655-664

  Holliday, Nicholas D ^a   Lam, Chi Wing ^a   Tough, Iain R ^a   Cox, Helen M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; GREEN FLUORESCENT PROTEIN; HEMAGGLUTININ; MUTANT PROTEIN; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; SERINE; THREONINE; TRANSFERRIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL STRAIN HEK293; CHO CELL; COLON CARCINOMA; CONTROLLED STUDY; DESENSITIZATION; EMBRYO CELL; ENDOCYTOSIS; ENDOSOME; EPITHELIUM; GENETIC TRANSFECTION; HAMSTER; HUMAN; HUMAN CELL; INTERNALIZATION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CELL LINE; CHO CELLS; CRICETINAE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN CONFORMATION; RATS; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE Y; TRANSFECTION;

EID: 14944381164     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.006114     Document Type: Article

References (40)

1. Beau I, Groyer-Picard MT, Desroches A, Condamine E, Leprince J, Tome JP, Dessen P, Vaudry H, and Misrahi M (2004) The basolateral sorting signals of the thyrotropin and luteinizing hormone receptors: an unusual family of signals sharing an unusual distal intracellular localization, but unrelated in their structures. Mol Endocrinol 18:733-746.
2. Berglund MM, Schober DA, Statnick MA, McDonald PH, and Gehlert DR (2003) The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced β-arrestin 2 interaction. J Pharmacol Exp Ther 306:147-156.
3. 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature (Lond) 333:370-373.
4. Braun L, Christophe T, and Boulay F (2003) Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a β-arrestin, dynamin and clathrin-dependent pathway. J Biol Chem 278:4277-4285.
5. Brzostowski JA and Kimmel AH (2001) Signaling at zero G: G-protein-independent functions for 7-TM receptors. Trends Biochem Sci 26:291-297.
6. Cox HM and Tough IR (2002) Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa. Br J Pharmacol 135:1505-1512.
7. Fraile-Ramos A, Kohout TA, Waldhoer M, and Marsh M (2003) Endocytosis of the viral chemokine receptor US28 does not require beta-arrestins but is dependent on the clathrin-mediated pathway. Traffic 4:243-253.
8. 1 receptor-mediated mechanism. Neuroscience 125: 703-709.
9. 1 receptor. J Biol Chem 277:6645-6655.
10. Gurevich W and Gurevich EV (2004) The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 25:105-111.
11. Hansel DE, Eipper BA, and Ronnett GV (2001) Neuropeptide Y functions as a neuroproliferative factor. Nature (Lond) 410:940-944.
12. 1 receptor. Br J Pharmacol 139:501-512.
13. Kisselev OG, McDowell JH, and Hargrave PA (2004) The arrestin-bound conformation and dynamics of the phosphorylated carboxy-terminal region of rhodopsin. FEBS Lett 564:307-311.
14. 1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol Pharmacol 41:817-821.
15. Leterrier C, Bonnard D, Carrel D, Rossier J, and Lenkei Z (2004) Constitutive endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem 279:36013-36021.
16. 2+ interactions affecting epithelial chloride secretion in human cultured colonic epithelia. Br J Pharmacol 108:462-468.
17. Mannon PJ (2002) Peptide YY as a growth factor for intestinal epithelium. Peptides 23:383-388.
18. Marsh KA, Stamp GWH, and Kirkland SC (1993) Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumourigenicity of these cells in a xenograft system. J Pathol 170:441-450.
19. McCarthy JB, Lim ST, Elkind NB, Trimmer JS, Duvoisin RM, Rodriguez-Boulan E, and Caplan MJ (2001) The C-terminal tail of the metabotropic glutamate receptor subtype 7 is necessary but not sufficient for cell surface delivery and polarized targeting in neurons and epithelia. J Biol Chem 276:9133-9140.
20. 2+ mobilization in HEL-cells. Br J Pharmacol 112:499-504.
21. Michel MC, Beck-Sickinger AG, Cox HM, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz TW, and Westfall T (1998) XVI international union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev 50:143-150.
22. Morris DP, Price RR, Smith MP, Lei B, and Schwinn DA (2004) Cellular trafficking of human α1a-adrenergic receptors is continuous and primarily agonist-independent. Mol Pharmacol 66:843-854.
23. Neuschafer-Rube F, Hermosilla R, Rehwald M, Ronnstrand L, Schulein R, Wernstedt C, and Puschel GP (2004) Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site. Biochem J 379:573-585.
24. Ohguro H, Palczewski K, Ericsson LH, Walsh KA, and Johnson RS (1993) Sequential phosphorylation of rhodopsin at multiple sites. Biochemistry 32:5718-5724.
25. Paing MM, Temple BR, and Trejo J (2004) A tyrosine-based sorting signal regulates intracellular trafficking of protease-activated receptor-1: multiple regulatory mechanisms for agonist-induced G protein-coupled receptor internalization. J Biol Chem 279:21938-21947.
26. Parent JL, Labrecque P, Driss RM, and Benovic JL (2001) Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: identification of a distinct motif for tonic internalization. J Biol Chem 276:7079-7085.
27. Parker SL, Kane JK, Parker MS, Berglund MM, Lundell IA, and Li MD (2001) Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem 268:877-886.
28. Pedrazzini T, Seydoux J, Künstner P, Aubert J-F, Grouzmann E, Beerman F, and Brunner H-R (1998) Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4:722-726.
29. Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, and Quirion R (2003) Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol 139:695-704.
30. Roy AA, Lemberg KE, and Chidiac P (2003) Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Mol Pharmacol 64:587-593.
31. Schwartkop CP, Kreienkamp HJ, and Richter D (1999) Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2 (delta349). J Neurochem 72:1275-1282.
32. Shenoy SK and Lefkowitz RJ (2003) Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375:503-515.
33. Sitaraman SV, Wang L, Wong M, Bruewer M, Robert M, Yun CH, Merlin D, and Madara JL (2002) The adenosine 2b receptor is recruited to the plasma membrane and associates with E3KARP and Ezrin upon agonist stimulation. J Biol Chem 277:33188-33195.
34. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, McCaffrey MW, and Morris R (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO (Eur Mol Biol Organ) J 22:3591-3601.
35. Tao J, Wang HY, and Malbon CC (2003) Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor. EMBO (Eur Mol Biol Organ) J 22:6419-6429.
36. 1 receptors interaction with anti-receptor antibodies. Eur J Biochem 255:595-603.
37. Wieland HA, Engel W, Eberlain W, Rudolf K, and Doods HN (1998b) Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol 125:549-555.
38. Willets JM, Challiss RA, and Nahorski SR (2003) Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol Sci 24:626-633.
39. Xiang Y, Devic E, and Kobuka B (2002) The PDZ binding motif of the β1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biol Chem 277:33783-33790.
40. Zhang X, Tong YG, Bao L, and Hökfelt T (1999) The neuropeptide Y Y1 receptor is a somatic receptor on dorsal root ganglion neurons and a postsynaptic receptor on somatostatin dorsal horn neurons. Eur J Neurosci 11:2211-2225.